Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,843.00
+92.00 (1.60%)
Mar 27, 2026, 2:03 PM JST
Kobayashi Pharmaceutical Market Cap
Kobayashi Pharmaceutical has a market cap or net worth of 427.52 billion as of March 26, 2026. Its market cap has increased by 4.56% in one year.
Market Cap
427.52B
Enterprise Value
357.60B
Revenue
165.74B
Ranking
n/a
PE Ratio
116.94
Stock Price
5,843.00
Market Cap Chart
Since August 17, 1999, Kobayashi Pharmaceutical's market cap has increased from 245.70B to 427.52B, an increase of 74.00%. That is a compound annual growth rate of 2.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 427.52B | 5.95% |
| Dec 30, 2025 | 403.51B | -12.87% |
| Dec 30, 2024 | 463.13B | -8.08% |
| Dec 29, 2023 | 503.84B | -22.52% |
| Dec 30, 2022 | 650.29B | -7.68% |
| Dec 30, 2021 | 704.43B | -28.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.60T |
| Shiseido Company | 1.22T |
| Rohto Pharmaceutical | 536.21B |
| Lion Corporation | 445.13B |
| KOSE Holdings | 333.98B |
| Pola Orbis Holdings | 287.43B |
| Paltac | 284.37B |
| MTG Co., Ltd. | 229.57B |